Improvements testing models and the understanding of Parkinson’s disease will help guide future drug development in the indication. Credit: Antonio Marca / Shutterstock.com. Preclinical and clinical ...

Explore the elite world of Navy Hospital Corpsmen in special operations medicine, including SARCs (Special Amphibious Reconnaissance Corpsmen), DMTs (Dive Medical Technicians), and SMTs (Search and ...

Background Disease-modifying therapies (DMTs) for Alzheimer’s disease (AD) have early evidence of efficacy. Widespread delivery of DMTs will require major service reconfiguration. Treatment pathways ...

Relapse rates in pediatric-onset multiple sclerosis were highest after injectable-to-injectable switching and lowest after infusion therapy, indicating benefit from treatment escalation. Children with ...

Disease-modifying therapies (DMTs) significantly slow brain volume loss in multiple sclerosis patients. Reduced brain volume loss directly correlates with decreased long-term disability progression in ...

Please provide your email address to receive an email when new articles are posted on . The model predicted a 12.6% average risk for recurrent disease activity among DMT discontinuers. The model’s AUC ...

If you’ve ever pulled a pint of dry-hopped beer only to be met with an unexpected whiff of cabbage, you’re not alone — and now you’ve got the research to back you up. Using GCxGC/SCD (that’s ...

4 Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain Background Great advances have been made in ...

Disease-modifying therapies (DMTs) may help lower the risk of children’s bone fractures among young patients with spinal muscular atrophy (SMA), a study by U.S. researchers suggests. “Drug therapy led ...